|
|||||
|
|
Reply to: Prophylactic use of deferiprone (L1) and MRI T2* or T2 for preventing heart disease in thalassaemia |
|
| Authors: | Chaim Hershko Maria D. Cappellini Renzo Galanello Antonio Piga Gianni Tognoni Giuseppe Masera |
| Affiliation: | Hebrew University Hadassah Medical School, Jerusalem and Ben Gurion University Faculty of Medicine, Beer Sheva;, Centre of Congenital Anaemia, Ospedale Policlinico Milano;, Department of Biomedical Science and Biotechnology, Cagliari;, Department of Paediatric Haematology, University of Turin, Turin;, Mario Negri Pharmacologic Resarch Institute Milano;, and Clinica Pediatrica, Ospedale San Gerardo, Milano, Italy. E-mail: |
| Abstract: | |
| Keywords: | heart disease thalassaemia deferiprone deferoxamine |